3 Pathology Lab, Boron Chemical and Edible Oil Stocks With a Strong Future Roadmap: Suraksha Diagnostic, Indo Borax & Chemicals and AWL Agri Business

Pathology lab, boron chemical and edible oil stocks give investors exposure to health tests, industrial chemicals and food staples used every day. Volumes, lab additions and margins decide how much of that demand turns into profit.

Readers comparing pathology lab, boron chemical and edible oil stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.

This list covers three pathology lab, boron chemical and edible oil stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, Indo Borax & Chemicals for boron-based chemicals such as boric acid and borax used in glass, ceramics and agriculture and AWL Agri Business for edible oils, packaged foods and staples sold under the Fortune brand. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Pathology Lab, Boron Chemical and Edible Oil Stocks?

Pathology lab, boron chemical and edible oil stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Pathology Lab, Boron Chemical and Edible Oil Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three pathology lab, boron chemical and edible oil stocks as of the 14 Oct 2026 close.

Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.

Why Do Pathology Lab, Boron Chemical and Edible Oil Stocks Have a Strong Roadmap in India?

Pathology lab, boron chemical and edible oil stocks have a strong roadmap in India because preventive health checks, glass and ceramic output and packaged staples keep adding volumes for these firms. Three drivers stand out.

• Preventive health: Families test more often and earlier.
• Industrial chemicals: Glass, ceramics and farms use boron products.
• Packaged staples: Branded oils and foods win share from loose products.

Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline

Suraksha Diagnostic's roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.

Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.

Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P/E of 46.05 against an industry P/E of 62.79, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.

Indo Borax & Chemicals: Boron Chemicals Anchor the Roadmap

Indo Borax's roadmap rests on boron-based chemicals such as boric acid and borax used in glass, ceramics and agriculture, with wide industrial usage supporting volumes.

Revenue grew from Rs 178.93 crore in FY22 to Rs 230.89 crore in FY26, a 29.0% rise, and FY26 revenue was 21.0% higher than FY25. FY26 net profit rose 18.3% to Rs 50.27 crore. Over four years, net profit rose from Rs 36.37 crore in FY22 to Rs 50.27 crore. In Q1 FY27, revenue grew 28.9% to Rs 72.92 crore, and net profit rose 59.3% to Rs 16.25 crore. Operating margin was 27.28% in FY26 and 31.78% in Q1 FY27 against 28.43% a year earlier.

Debt to equity is 0.00 and return on equity is 11.09%. FY26 operating cash flow was Rs 87.15 crore against capital expenditure of Rs 0.29 crore. Indo Borax paid a dividend of Rs 1 per share for FY26, a yield of 0.21%. At a P/E of 27.49 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 31.78% against 27.28% for FY26, so margin stability is the figure to follow as volumes grow.

AWL Agri Business: Edible Oils and Staples Build the Next Leg

AWL Agri's roadmap rests on edible oils, packaged foods and staples sold under the Fortune brand, with a wide distribution network supporting volumes.

Revenue grew from Rs 54,327.16 crore in FY22 to Rs 75,148.47 crore in FY26, a 38.3% rise, and FY26 revenue was 17.6% higher than FY25. FY26 net profit was Rs 990.44 crore. In Q1 FY27, revenue grew 16.5% to Rs 20,116.91 crore, and net profit rose 47.7% to Rs 351.39 crore. Operating margin was 3.38% in FY26 and 3.90% in Q1 FY27 against 3.39% a year earlier.

Debt to equity is 0.11 and return on equity is 9.98%. FY26 operating cash flow was Rs 3,928.34 crore against capital expenditure of Rs 833.37 crore. AWL Agri paid a dividend of Rs 1 per share for FY26, a yield of 0.55%. At a P/E of 20.49 against an industry P/E of 34.85, the stock trades below its industry multiple.

What to watch: Net profit margin is only 1.3%, so small cost changes move earnings.

Best Pathology Lab, Boron Chemical and Edible Oil Stocks in India: Suraksha Diagnostic vs Indo Borax vs AWL Agri on Key Financials

Among the best pathology lab, boron chemical and edible oil stocks in India, Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; Indo Borax leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; AWL Agri leads on the lowest P/E and dividend yield. The table puts the numbers side by side.

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Pathology Lab, Boron Chemical and Edible Oil Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen pathology lab, boron chemical and edible oil stocks and shortlist pathology lab, boron chemical and edible oil stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these pathology lab, boron chemical and edible oil stocks

Risks to Consider Before Investing in Pathology Lab, Boron Chemical and Edible Oil Stocks

• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Suraksha Diagnostic, Indo Borax and AWL Agri live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover diagnostics, boron chemicals and edible oils. Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; Indo Borax leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; AWL Agri leads on the lowest P/E and dividend yield.

Across pathology lab, boron chemical and edible oil stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the pathology lab, boron chemical and edible oil stocks to buy discussed here.

FAQs on Pathology Lab, Boron Chemical and Edible Oil Stocks

Which are the best pathology lab, boron chemical and edible oil stocks in India with a strong roadmap?

Ans. Suraksha Diagnostic, Indo Borax & Chemicals and AWL Agri Business stand out for their roadmaps in diagnostics, boron chemicals and edible oils. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 21.0% at Indo Borax and 17.6% at AWL Agri, and return on equity ranges from 9.98% to 13.15%.

Is Suraksha Diagnostic a good stock to buy now?

Ans. Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P/E of 46.05 against an industry P/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Suraksha Diagnostic, Indo Borax and AWL Agri?

Ans. The P/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 27.49 for Indo Borax (industry 36.60) and 20.49 for AWL Agri (industry 34.85). All of them trade below the industry multiple.

Which of these pathology lab, boron chemical and edible oil stocks has the highest return on equity?

Ans. Suraksha Diagnostic has the highest return on equity at 13.15%, followed by Indo Borax & Chemicals at 11.09% and AWL Agri Business at 9.98%.

What are the risks of investing in pathology lab, boron chemical and edible oil stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Suraksha Diagnostic, Indo Borax and AWL Agri perform in Q1 FY27?

Ans. Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. Indo Borax & Chemicals reported revenue of Rs 72.92 crore, up 28.9% year on year, and net profit rose 59.3% to Rs 16.25 crore. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.

Do pathology lab, boron chemical and edible oil stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 0.21% for Indo Borax and 0.55% for AWL Agri, based on dividends declared for FY26.

How can I invest in pathology lab, boron chemical and edible oil stocks in India?

Ans. You can buy pathology lab, boron chemical and edible oil stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.